Reducing LDL-Cholesterol to Very Low Levels: Sailing Between Established Benefits and Potential Risks

Packard C, Chapman MJ, Sibartie M, Laufs U, Masana L. Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges. Heart. 2021;107(17):1369–75. https://doi.org/10.1136/heartjnl-2020-318760.

Article  PubMed  CAS  Google Scholar 

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, ESC Scientific Document Group, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–88. https://doi.org/10.1093/eurheartj/ehz455.

Article  PubMed  Google Scholar 

Cybulska B, Kłosiewicz-Latoszek L, Penson PE, Nabavi SM, Lavie CJ, Banach M, International Lipid Expert Panel (ILEP). How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors. Prog Cardiovasc Dis. 2021;67:65–74. https://doi.org/10.1016/j.pcad.2020.12.008.

Article  PubMed  Google Scholar 

Goldstein LB, Toth PP, Dearborn-Tomazos JL, Giugliano RP, Hirsh BJ, Peña JM, et al. American Heart Association Council on Arteriosclerosis,Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Stroke Council. Aggressive LDL-C lowering and the brain: impact on risk for dementia and hemorrhagic stroke: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2023;43:e404–42. https://doi.org/10.1161/ATV.0000000000000165.

Article  PubMed  CAS  Google Scholar 

Karagiannis AD, Mehta A, Dhindsa DS, Virani SS, Orringer CE, Blumenthal RS, Stone NJ, Sperling LS. How low is safe? The frontier of very low (< 30 mg/dL) LDL cholesterol. Eur Heart J. 2021;42(22):2154–69. https://doi.org/10.1093/eurheartj/ehaa1080.

Article  PubMed  CAS  Google Scholar 

Islam SMT, Osa-Andrews B, Jones PM, Muthukumar AR, Hashim I, Cao J. Methods of low-density lipoprotein-cholesterol measurement: analytical and clinical applications. EJIFCC. 2022;33:282–94.

PubMed  PubMed Central  CAS  Google Scholar 

Martins J, Steyn N, Rossouw HM, Pillay TS. Best practice for LDL-cholesterol: when and how to calculate. J Clin Pathol. 2023;76:145–52. https://doi.org/10.1136/jcp-2022-208480.

Article  PubMed  CAS  Google Scholar 

Miller WG, Myers GL, Sakurabayashi I, Bachmann LM, Caudill SP, Dziekonski A, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem. 2010;56(6):977–86. https://doi.org/10.1373/clinchem.2009.142810.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1046-e1081. https://doi.org/10.1161/CIR.0000000000000624

Taageby Nielsen S, Mohr Lytsen R, Strandkjar N, Juul Rasmussen I, Sillesen AS, Vøgg ROB, et al. Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life. Eur Heart J. 2023;44:4408–18. https://doi.org/10.1093/eurheartj/ehad547.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232(4746):34–47.

Article  PubMed  CAS  Google Scholar 

Hochholzer W, Giugliano RP. Lipid lowering goals: back to nature? Ther Adv Cardiovasc Dis. 2010;4(3):185–91.

Article  PubMed  CAS  Google Scholar 

Martin SS, Niles JK, Kaufman HW, Awan Z, Elgaddar O, Choi R, et al. Lipid distributions in the Global Diagnostics Network across five continents. Eur Heart J. 2023;44(25):2305–18.

Article  PubMed  PubMed Central  Google Scholar 

Langlois MR, Nordestgaard BG, Langsted A, Chapman MJ, Aakre KM, Baum H, et al. European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020;58(4):496–517.

Article  PubMed  CAS  Google Scholar 

Duan Y, Gong K, Xu S, Zhang F, Meng X, Han J. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Ther. 2022;7:265.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sharpe LJ, Coates HW, Brown AJ. Post-translational control of the long and winding road to cholesterol. J Biol Chem. 2020;295:17549–59.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Perego C, Da Dalt L, Pirillo A, Galli A, Catapano AL, Norata GD. Cholesterol metabolism, pancreatic β-cell function and diabetes. Biochim Biophys Acta Mol Basis Dis 2019;1865(9):2149–56.

Päth G, Perakakis N, Mantzoros CS, Seufert J. PCSK9 inhibition and cholesterol homeostasis in insulin producing β-cells. Lipids Health Dis. 2022;21(1):138.

Article  PubMed  PubMed Central  Google Scholar 

Matsui M, Sakurai F, Elbashir S, Foster DJ, Manoharan M, Corey DR. Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter. Chem Biol. 2010;17(12):1344–55.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225–45.

Article  PubMed  CAS  Google Scholar 

Schulz R, Schlüter K-D, Laufs U. Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9). Basic Res Cardiol. 2015;110:1–19.

Article  CAS  Google Scholar 

Olsson AG, Angelin B, Assmann G, Binder CJ, Björkhem I, Cedazo-Minguez A, et al. Can LDL cholesterol be too low? Possible risks of extremely low levels. J Intern Med. 2017;281:534–53.

Article  PubMed  CAS  Google Scholar 

Goldstein LB, Toth PP, Dearborn-Tomazos JL, Giugliano RP, Hirsh BJ, et al. American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Stroke Council. Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2023;43(10):e404–42.

Article  PubMed  CAS  Google Scholar 

Bredefeld C, Hussain MM, Averna M, Black DD, Brin MF, Burnett JR, et al. Guidance for the diagnosis and treatment of hypolipidemia disorders. J Clin Lipidol. 2022;16(6):797–812.

Article  PubMed  Google Scholar 

Gill PK, Hegele RA. Low cholesterol states: clinical implications and management. Expert Rev Endocrinol Metab. 2023;18(3):241–53.

Article  PubMed  CAS  Google Scholar 

Hooper AJ, Marais AD, Tanyanyiwa DM, Burnett JR. The C679X mutation in PCSK9 is present and lowers blood cholesterol in a southern African population. Atherosclerosis. 2007;193:445–8.

Article  PubMed  CAS  Google Scholar 

Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326:1423–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a mendelian randomization analysis. J Am Coll Cardiol. 2012;60(25):2631–9.

Article  PubMed  CAS  Google Scholar 

Rao AS, Lindholm D, Rivas MA, Knowles JW, Montgomery SB, Ingelsson E. Large-scale phenome-wide Association study of PCSK9 variants demonstrates Protection Against ischemic stroke. Circ Genom Precis Med. 2018;11(7):e002162.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ma C, Gurol ME, Huang Z, Lichtenstein AH, Wang X, Wang Y, et al. Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: a prospective study. Neurology. 2019;93(5):e445–57.

Article  PubMed  PubMed Central 

Comments (0)

No login
gif